PureTech Health (PureTech Health) EV-to-EBITDA : -24.35 (As of May. 01, 2024)

View and export this data going back to 2015. Start your Free Trial

What is PureTech Health EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, PureTech Health's enterprise value is $430.48 Mil. PureTech Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-17.68 Mil. Therefore, PureTech Health's EV-to-EBITDA for today is -24.35.

The historical rank and industry rank for PureTech Health's EV-to-EBITDA or its related term are showing as below:

PTCHF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -26.61 Med: -2.65 Max: 45.31
Current: -24.64

During the past 12 years, the highest EV-to-EBITDA of PureTech Health was 45.31. The lowest was -26.61. And the median was -2.65.

PTCHF's EV-to-EBITDA is ranked worse than
100% of 468 companies
in the Biotechnology industry
Industry Median: 9.155 vs PTCHF: -24.64

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-01), PureTech Health's stock price is $2.70. PureTech Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.240. Therefore, PureTech Health's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

PureTech Health EV-to-EBITDA Historical Data

The historical data trend for PureTech Health's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PureTech Health EV-to-EBITDA Chart

PureTech Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBITDA

Get a 7-Day Free Trial

2.16

41.79

-14.81

-7.59

-20.40

PureTech Health Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial															-14.81	-	-7.59	-	-20.40

Competitive Comparison of PureTech Health's EV-to-EBITDA

For the Biotechnology subindustry, PureTech Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PureTech Health's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PureTech Health's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where PureTech Health's EV-to-EBITDA falls into.

PureTech Health EV-to-EBITDA Calculation

PureTech Health's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	430.481	/	-17.682
	=	-24.35

PureTech Health's current Enterprise Value is $430.48 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PureTech Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-17.68 Mil.

PureTech Health (OTCPK:PTCHF) EV-to-EBITDA Explanation

PureTech Health's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	2.70	/	-0.240
	=	At Loss

PureTech Health's share price for today is $2.70.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PureTech Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.240.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

PureTech Health EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of PureTech Health's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

PureTech Health (PureTech Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PureTech Health PLC (OTCPK:PTCHF) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

PRTC:USA PRTCl:UK PRTC:UK PRTCL:Germany

Address

6 Tide Street, Suite 400, Boston, MA, USA, 02210

Website

https://www.puretechhealth.com

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.